Under QPRT inhibition, NAD+ synthesis is secured by the activation of a salvage pathway, often preferred by cancer cells, in which nicotinamide is converted by nicotinamide phosphoribosyltransferase (NAMPT) into NAD+ [137]. Here, NAMPT is linked to cancer.